| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $135K | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $135K | — |
| R&D Expense | $9.1M | +52.4% |
| SG&A Expense | $8.9M | +7.7% |
| Operating Income | -$17.8M | -25.6% |
| Interest Expense | $244K | -77.4% |
| Pre-tax Income | -$24.8M | +5.4% |
| Income Tax | $3K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $112K | — |
| Inventory | $0 | — |
| Current Assets | $3.8M | +63.2% |
| Total Assets | $4.7M | +32.6% |
| Current Liabilities | $6.8M | -47.6% |
| Long-term Debt | $4.1M | +0.0% |
| Total Liabilities | $6.8M | -60.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | -55.6% |
| Financing Cash Flow | $17.6M | +69.5% |
| Net Income | -$24.8M | +5.3% |
| EPS (Basic) | -$6.63 | -447.9% |
| EPS (Diluted) | -$6.63 | -447.9% |
| Stockholders' Equity |
| -$2.2M |
| +84.3% |